Mirza, M. R., Bjørge, L., Marmé, F., Christensen, R. D., Gil-Martin, M., Auranen, A., . . . Sehouli, J. (2025). Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial. Gynecologic oncology, 192, . https://doi.org/10.1016/j.ygyno.2024.12.003
Chicago-Zitierstil (17. Ausg.)Mirza, Mansoor R., et al. "Palbociclib Plus Letrozole in Estrogen Receptor-positive Advanced/recurrent Endometrial Cancer: Double-blind Placebo-controlled Randomized Phase II ENGOT-EN3/PALEO Trial." Gynecologic Oncology 192 (2025). https://doi.org/10.1016/j.ygyno.2024.12.003.
MLA-Zitierstil (9. Ausg.)Mirza, Mansoor R., et al. "Palbociclib Plus Letrozole in Estrogen Receptor-positive Advanced/recurrent Endometrial Cancer: Double-blind Placebo-controlled Randomized Phase II ENGOT-EN3/PALEO Trial." Gynecologic Oncology, vol. 192, 2025, https://doi.org/10.1016/j.ygyno.2024.12.003.